Terms: = Gastric cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
40 results:
1. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.
Garmezy B; Borad MJ; Bahleda R; Perez CA; Chen LT; Kato S; Oh DY; Severson P; Tam BY; Quah CS; Harding JJ
Cancer Res Commun; 2024 Apr; 4(4):1165-1173. PubMed ID: 38602417
[TBL] [Abstract] [Full Text] [Related]
2. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
3. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
4. Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse gastric cancer.
Liu ZX; Zhang XL; Zhao Q; Chen Y; Sheng H; He CY; Sun YT; Lai MY; Wu MQ; Zuo ZX; Wang W; Zhou ZW; Wang FH; Li YH; Xu RH; Qiu MZ
JAMA Netw Open; 2022 Dec; 5(12):e2245836. PubMed ID: 36484990
[TBL] [Abstract] [Full Text] [Related]
5. Novel insights into immunohistochemical analysis for diagnosing serous neoplasm of the pancreas: aquaporin 1, stereocilin, and transmembrane protein 255B.
Watase C; Fuse M; Ino Y; Naito C; Hiraoka N
Histopathology; 2021 Nov; 79(5):872-879. PubMed ID: 34288030
[TBL] [Abstract] [Full Text] [Related]
6. Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2.
Du G; Jiang J; Wu Q; Henning NJ; Donovan KA; Yue H; Che J; Lu W; Fischer ES; Bardeesy N; Zhang T; Gray NS
Angew Chem Int Ed Engl; 2021 Jul; 60(29):15905-15911. PubMed ID: 33915015
[TBL] [Abstract] [Full Text] [Related]
7. Comparative effectiveness of treatment modalities in non-metastatic gastric adenocarcinoma: a propensity score matching analysis of the National cancer Database.
Barzi A; Yang D; Kim AW; Shah MA; Sadeghi S
BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33148789
[TBL] [Abstract] [Full Text] [Related]
8. fgfr3
Jin Z; Feng H; Liang J; Jing X; Zhao Q; Zhan L; Shen B; Cheng X; Su L; Qiu W
Cell Death Dis; 2020 Oct; 11(10):903. PubMed ID: 33097695
[TBL] [Abstract] [Full Text] [Related]
9. Precision medicine for human cancers with Notch signaling dysregulation (Review).
Katoh M; Katoh M
Int J Mol Med; 2020 Feb; 45(2):279-297. PubMed ID: 31894255
[TBL] [Abstract] [Full Text] [Related]
10. [Effects of Aging on Endothelium-dependent Vasodilation of Human Artery].
Li QY; Zhu MJ; Chen L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 50(2):210-214. PubMed ID: 31106541
[TBL] [Abstract] [Full Text] [Related]
11. Somatic mutational profiles of stage II and III gastric cancer according to tumor microenvironment immune type.
Koh J; Nam SK; Roh H; Kim J; Lee BC; Kim JW; Ahn SH; Park DJ; Kim HH; Park KU; Chung JH; Kim WH; Lee HS
Genes Chromosomes Cancer; 2019 Jan; 58(1):12-22. PubMed ID: 30239046
[TBL] [Abstract] [Full Text] [Related]
12. SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models.
Jiang XF; Dai Y; Peng X; Shen YY; Su Y; Wei MM; Liu WR; Ding ZB; Zhang A; Shi YH; Ai J
Acta Pharmacol Sin; 2018 Feb; 39(2):243-250. PubMed ID: 28905937
[TBL] [Abstract] [Full Text] [Related]
13. A systematic review of the possible carcinogenic role of the aristolochic acid.
Bara T; Gurzu S; Sugimura H; Bara T; Beleaua MA; Jung I
Rom J Morphol Embryol; 2017; 58(1):41-44. PubMed ID: 28523296
[TBL] [Abstract] [Full Text] [Related]
14. Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation.
Yu H; Xia H; Tang Q; Xu H; Wei G; Chen Y; Dai X; Gong Q; Bi F
Sci Rep; 2017 Jan; 7():40802. PubMed ID: 28102288
[TBL] [Abstract] [Full Text] [Related]
15. Therapeutics Targeting FGF Signaling Network in Human Diseases.
Katoh M
Trends Pharmacol Sci; 2016 Dec; 37(12):1081-1096. PubMed ID: 27992319
[TBL] [Abstract] [Full Text] [Related]
16. An fgfr3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in gastric cancer Patients.
Piro G; Carbone C; Cataldo I; Di Nicolantonio F; Giacopuzzi S; Aprile G; Simionato F; Boschi F; Zanotto M; Mina MM; Santoro R; Merz V; Sbarbati A; de Manzoni G; Scarpa A; Tortora G; Melisi D
Clin Cancer Res; 2016 Dec; 22(24):6164-6175. PubMed ID: 27267856
[TBL] [Abstract] [Full Text] [Related]
17. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract] [Full Text] [Related]
18. MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells.
Yang T; He W; Cui F; Xia J; Zhou R; Wu Z; Zhao Y; Shi M
Oncotarget; 2016 Apr; 7(14):18085-94. PubMed ID: 26919111
[TBL] [Abstract] [Full Text] [Related]
19. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation.
Haverkamp L; van der Sluis PC; Ausems MG; van der Horst S; Siersema PD; Ruurda JP; Offerhaus GJ; van Hillegersberg R
J Gastrointest Surg; 2015 Dec; 19(12):2120-5. PubMed ID: 26443527
[TBL] [Abstract] [Full Text] [Related]
20. Muscarinic receptor M3 mediates cell proliferation induced by acetylcholine and contributes to apoptosis in gastric cancer.
Wang L; Zhi X; Zhang Q; Wei S; Li Z; Zhou J; Jiang J; Zhu Y; Yang L; Xu H; Xu Z
Tumour Biol; 2016 Feb; 37(2):2105-17. PubMed ID: 26346168
[TBL] [Abstract] [Full Text] [Related]
[Next]
